It has also been shown that the treatment of human A2058 melanoma cells with a small-molecule STAT3 inhibitor, CPA-7 was effective at inhibiting the expression of HIF-1α and VEGF in vitro and tumour growth and angiogenesis of human A2058 melanoma tumours in vivo [33]. This evidence concerns the gene STAT3 and melanoma.